The emphasis on sustainability and green chemistry within undergraduate labs mirrors efforts by UC Berkeley’s department of ...
IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive ...
The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.
The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback